Growth Metrics

Merck (MRK) Gross Margin (2016 - 2025)

Merck (MRK) has disclosed Gross Margin for 17 consecutive years, with 66.15% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin fell 935.0% to 66.15% in Q4 2025 year-over-year; TTM through Dec 2025 was 74.8%, a 152.0% decrease, with the full-year FY2025 number at 74.8%, down 152.0% from a year prior.
  • Gross Margin was 66.15% for Q4 2025 at Merck, down from 77.69% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 77.98% in Q1 2025 to a low of 66.15% in Q4 2025.
  • A 5-year average of 73.4% and a median of 73.27% in 2023 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: soared 5462bps in 2021, then tumbled -935bps in 2025.
  • Merck's Gross Margin stood at 71.35% in 2021, then rose by 1bps to 71.94% in 2022, then rose by 2bps to 73.26% in 2023, then increased by 3bps to 75.5% in 2024, then decreased by -12bps to 66.15% in 2025.
  • Per Business Quant, the three most recent readings for MRK's Gross Margin are 66.15% (Q4 2025), 77.69% (Q3 2025), and 77.5% (Q2 2025).